Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
Azactam CMI 20 Jun 2019
Revlimid PI 19 Jun 2019
Taltz PI 19 Jun 2019
Duavive PI 19 Jun 2019
Duavive CMI 19 Jun 2019

New products

Product name Type Date released
Tenofovir Disoproxil Emtricitabine Efavirenz Mylan PI 14 Jun 2019
BTC Lercanidipine CMI 06 Jun 2019
BTC Lercanidipine PI 06 Jun 2019
Lercanidipine APOTEX CMI 06 Jun 2019
Lercanidipine APOTEX PI 06 Jun 2019